Immuron Limited (AU:IMC) has released an update.
Immuron Limited, an Australian biopharmaceutical company, announces that CEO Steven Lydeamore will present at The Watchlist on April 23, 2024, discussing the company’s product Travelan® and its sales growth, clinical advancements, and future plans. Following the presentation, a Q&A session will enable direct engagement with Lydeamore. The event will be accessible live via Zoom and a recorded version will be available afterwards.
For further insights into AU:IMC stock, check out TipRanks’ Stock Analysis page.
